Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
3 clinical trials · Condition
◉ Watch Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers (NCT03816332) | National Cancer Institute (NCI) | 2019-11-08 |
| Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (NCT03712605) | National Cancer Institute (NCI) | 2018-11-15 |
| Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma (NCT03304639) | National Cancer Institute (NCI) | 2018-06-12 |
Track Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.